New depression drug zuranolone one step closer to FDA ruling. Latest in the Clinical Pipeline, by CyrilPedia
The US Food and Drug Administration recently accepted Sage Therapeutics and Biogen’s filing for areceptor agonist, zuranolone , for the treatment of major depressive disorder and postpartum depression. The February announcement was followed by the
that it was unlikely to convene an advisory committee to review the application. The agency is scheduled to issue its ruling by 5 August 2023.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Good Medicine exhibit is a look into Indigenous healers and medicineThe Anchorage Museum's Good Medicine exhibit is a look at the Indigenous healers and medicine that have helped the residents of the north survive for millennia.
Weiterlesen »
In a Civilian Hospital, Military Medicine Is Kept AliveCivilian hospitals help Army doctors hang on to hard-earned lessons of combat medicine
Weiterlesen »
East New York Family Academy celebrates herstory - New York Amsterdam News“When you educate a woman, you educate a nation.” That African proverb reigns true to this day when we look at our community. Councilmember Charles Barron and his office hosted a closeout for Women’s Herstory Month
Weiterlesen »
New ads shame 'garbage' New Yorkers into picking up litter, dog waste'All I know is, if I see someone littering, I'll tell them where to stick it.'
Weiterlesen »
You can try The New York Times’ new math-based puzzle game right nowYou can try Digits’ beta for free.
Weiterlesen »
Tesla stock price falls on new price cuts, new Shanghai factoryTesla stock tumbles 5% after the EV maker cuts prices again
Weiterlesen »